Pharmaceutical products (Польша - Тендер #46537444)

1. Section I
   1. Name and addresses
      Instytut Gruźlicy i Chorób Płuc
      ul. Płocka 26
      Warszawa
      01-138
      Poland
      Telephone: +48 224312312
      E-mail: p.ossas@igichp.edu.pl
      Fax: +48 224312452
      
   2. Joint procurement
      
   3. Communication
      The procurement documents are available for unrestricted and full direct access, free of charge, at
      https://igichp.ezamawiajacy.pl
      Additional information can be obtained from the abovementioned addressto the abovementioned address
      
   4. Type of the contracting authority:
      Body governed by public law
      
   5. Main activity:
      Health
      
2. Section II
   1. Scope of the procurement:
      1. Title:
         

         Dostawa produktów leczniczych określonych w 12 pakietach.

         Reference number: AP.26.100.2023
         
      2. Main CPV code:
         33600000
         
      3. Type of contract:
         Supplies
         
      4. Short description:
         

         Przedmiotem zamówienia jest dostawa produktów leczniczych określonych w 12 pakietach.

      5. Estimated total value:
         
         
      6. Information about lots:
         all lots
   2. Description
      1. Title:
         

         Pakiet Nr 1

         Lot No: 1
         
      2. Additional CPV code(s):
         33622600, 33631500, 33651400, 33661000
         
      3. Place of performance:
         Main site or place of performance:

         Instytut Gruźlicy i Chorób Płuc z siedzibą w Warszawie 01-138, ul. Płocka 26 - Apteka.

      4. Description of the procurement:
         

         Pakiet Nr 1: Aciclovir 250 mg x 5 fiol. - 15 op., Ambroxol 15mg/2ml x 10 amp. – 600 op., Bisoprolol 2,5mg x 60 tabl. powl. – 130 op., Bisoprolol 5mg x 60 tabl. powl. – 100 op., Captopril 12,5mg x 30 tabl. – 80 op., Captopril 25 mg x 30 tabl. – 80 op., Deksametazon 4mg/1ml 10 amp. – 700 op., Deksametazon 8mg/2ml 10 amp. – 150 op., Hydrocortyzon 100mg x 5 fiol. – 800 op., Hydroksyzyna 10mg x 60 tabl. powl. – 250 op., Hydroksyzyna 25mg x 60 tabl. powl. – 350 op., Lidokaina 20mg/1g x 30g żel anestezjologiczy – 120 op., Lidokaina 20mg/1g x 30g żel urologiczny – 40 op., Rocuronium 100 mg /10ml x 10fiol. – 300 op., Suksametonium 200mg x 10 fiol. – 80 op., Sulfathiazolum argentum 20mg/1g x 40g krem – 220 op.

      5. Award criteria:
         
      6. Estimated value:
         
         
      7. Duration of the contract, framework agreement or dynamic purchasing system:
         Duration in months: 6
         This contract is subject to renewal: no
         
      8. Information about the limits on the number of candidates to be invited:
         
      9. Information about variants:
         Variants will be accepted: no
         
      10. Information about options:
          Options: no
      11. Information about electronic catalogues:
          
          
      12. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      13. Additional information:
          
      14. Title:
          

          Pakiet Nr 2

          Lot No: 2
          
      15. Additional CPV code(s):
          33622600, 33631500, 33642000, 33651400, 33661000, 33615000
          
      16. Place of performance:
          Main site or place of performance:

          Instytut Gruźlicy i Chorób Płuc z siedzibą w Warszawie 01-138, ul. Płocka 26 - Apteka.

      17. Description of the procurement:
          

          Pakiet Nr 2: Ambroxol 30 mg x 10 tabl. – 500 op., Bilastine 20 mg x 30 tabl. – 40 op., Dexketoprofen 25 mg x 30 tabl. – 300 op., Dexketoprofen 25 mg/2,5g x 20 sasz. – 30 op., Dexketoprofen 50 mg/ 2ml x 5 amp. – 900 op., Ketoprofen 25 mg/g żel 100 g – 50 op., Heparyna 1000 j.m./1g x 30 g – 200 op., Lercanidipine 10 mg x 60 tabl. – 10 op., Lewotyroksyna 50 mcg x 50 tabl. – 200 op., Lewotyroksyna 88 mcg x 50 tabl. – 10 op., Lewotyroksyna 75 mcg x 50 tabl. – 20 op., Lewotyroksyna 100 mcg x 50 tabl. – 160 op., Metformin 500 mg x 60 tabl. – 300 op., Metformin 850 mg x 60 tabl. – 200 op., Metformin 1000 mg x 60 tabl. – 150 op., Nebivolol 5 mg x 28 tabl. – 350 op., Nimesulid 100mg/2g x 30 sasz. – 40 op., Proteinianobursztynian żelaza III 800mg/15ml (40mg Fe3+) x 20 fiol. – 60 op., Simeticonum 40 mg / 1 ml a 30 ml – 20 op., Simeticonum 40 mg x 100 kaps. – 50 op., Torasemide 5 mg x 30 tabl. – 160 op., Torasemide 10 mg x 30 tabl. – 120 op., Torasemide 20 mg/4 ml x 5 amp. – 60 op., Torasemide 200 mg/20 ml x 5 amp. – 10 op., Tramadolum75 mg+Dexketoprofenum 25 mg x 20 tabletek – 30 op., Umeclidinium 55 µg/ dawka, prosz.do inh. x 30 dawek – 100 op., Umeclidinium+Vilanterol (55µg+22µg) /dawka, prosz.do inh. x 30 dawek – 100 op., Zofenopril 30 mg x 28 tabl. – 20 op., Zofenopril 7,5 mg x 28 tabl. – 50 op.

      18. Award criteria:
          
      19. Estimated value:
          
          
      20. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 6
          This contract is subject to renewal: no
          
      21. Information about the limits on the number of candidates to be invited:
          
      22. Information about variants:
          Variants will be accepted: no
          
      23. Information about options:
          Options: no
      24. Information about electronic catalogues:
          
          
      25. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      26. Additional information:
          
      27. Title:
          

          Pakiet Nr 3

          Lot No: 3
          
      28. Additional CPV code(s):
          33610000, 33612000, 33615000, 33616000, 33617000, 33620000, 33621100, 33622000, 33622200, 33622300, 33622600, 33632100, 33642200, 33651200, 33670000
          
      29. Place of performance:
          Main site or place of performance:

          Instytut Gruźlicy i Chorób Płuc z siedzibą w Warszawie 01-138, ul. Płocka 26 - Apteka.

      30. Description of the procurement:
          

          Pakiet Nr 3: Acetylocysteina 200mg x 20 tabl. – 500 op., Acetylocysteina 300mg/3ml x 5 amp. – 1 100 op., Acetylocysteina 600mg x10 tabl. mus. – 1 000 op., Allopurinol 100 mg x 50 tabl. – 300 op., Allopurinol 300 mg x 30 tabl. – 50 op., Amlodypina 5 mg x 30 tabl. – 400 op., Amlodypina 10 mg x 30 tabl. – 200 op., Amoksycylina 1,0 g x 20 tabl. powl. – 40 op., Amoksycylina+ Kw.Klawulanowy 625 mg (500mg+125mg) x 14 tabl. – 30 op., Amoksycylina+ Kw.Klawulanowy 1000 mg (875mg+125mg) x 14 tabl. – 600 op., amoksycylina+Kw.Klawulanowy 1,2 g (1,0 g+0,2 g) x 5 fiol. – 1 800 op., Atrowastatyna 20 mg x 60 tabl. – 200 op., Bisoprolol 1,25 mg x 30 tabl. – 300 op., Bisoprolol 5 mg x 30 tabl. – 500 op., Budezonid 50 µg/dawka, aer. do nosa x 200 dawek – 20 op., Candesartan 8 mg x 28 tabl. – 50 op., Candesartan 16 mg x 28 tabl. – 30 op., Diklofenak 50 mg x 10 czopków – 40 op., Diklofenak 100 mg x 10 czopków – 160 op., Diklofenak 50 mg x 50 tabl. – 100 op., Formoterol 12µg/dawka, prosz. do inh.x 60 kaps. – 100 op., Ketoprofen 100 mg x 30 tabl. – 800 op., Ketoprofen 100 mg/2ml x 10 amp. – 1 400 op., Klindamycyna 300 mg x 16 kaps. – 100 op., Klindamycyna 300mg/2 ml x 5 amp. – 120 op., Levofloxacyna 500mg/100ml x 5szt. – 300 op., Loratadyna 10 mg x 30 tabl. – 25 op., Metoprolol 23.75mg x 30 tabl. o przedłużonym uwalnianiu – 170 op., Metoprolol 47,5mg x 30 tabl. o przedłużonym uwalnianiu – 150 op., Metoprolol 95mg x 30 tabl. o przedłużonym uwalnianiu – 100 op., Nebivolol 5 mg x 28 tabl. – 200 op., Pantoprazol 20mg x 56 tabl. – 600 op., Pantoprazol 40mg x 10 fiol. – 1 200 op., Pantoprazol 40mg x 56 tabl. – 550 op., Phenoxymethylpenicillin 1.5mln j.m. x 12 tabl. powl. – 10 op., Piperacillin/Tazobactam 4,0g/0,5g x 10 fiol. – 400 op., Ramipril 1,25 mg x 30 tabl. – 25 op., Ramipril 2,5 mg x 30 tabl. – 200 op., Ramipril 5 mg x 30 tabl. – 250 op., Ramipril 10 mg x 30 tabl. – 80 op., Rosuvastatin 10 mg x 28 tabl. – 300 op., Salmeterol 25µg/dawka aerozol x 120 dawek – 20 op., Sotalol 80 mg x 20 tabl. – 50 op., Telmisartan 40 mg x 28 tabl. – 100 op., Telmisartan 80 mg x 28 tabl. – 100 op., Voriconazole 200 mg x 1 fiol. – 80 op., Walproinian sodu+Kw.walproinowy 300 mg x 30 tabl. o przedł. uwal. – 30 op., Walproinian sodu+Kw.walproinowy 500 mg x 30 tabl. o przedł. uwal. – 30 op., Vankomycyna 500 mg x 1 fiol. – 1 000 op., Vankomycyna 1000 mg x 1 fiol. – 1 000 op.

      31. Award criteria:
          
      32. Estimated value:
          
          
      33. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 6
          This contract is subject to renewal: no
          
      34. Information about the limits on the number of candidates to be invited:
          
      35. Information about variants:
          Variants will be accepted: no
          
      36. Information about options:
          Options: no
      37. Information about electronic catalogues:
          
          
      38. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      39. Additional information:
          
      40. Title:
          

          Pakiet Nr 4

          Lot No: 4
          
      41. Additional CPV code(s):
          33617000, 33651100, 33661100, 33651200
          
      42. Place of performance:
          Main site or place of performance:

          Instytut Gruźlicy i Chorób Płuc z siedzibą w Warszawie 01-138, ul. Płocka 26 - Apteka.

      43. Description of the procurement:
          

          Pakiet Nr 4: 0,3% roztwór KCl z 0,9% NaCl x 10 but.a 500 ml – 50 op., 0,3% roztwór KCl z 0,9% NaCl x 10 but.a 1000 ml – 30 op., Amikacyna 500mg/100ml x 10 fl. – 100 op., Amikacyna 500mg/2ml x 1 fiol. – 10 op., Amikacyna 1,0g/100ml x 10 fl. – 150 op., Cefazolin 1,0g x 1 fiol. – 4 000 op., Cefotaksym 1,0g x1 fiol. – 300 op., Ceftazydym 1,0g x 1 fiol. – 6 000 op., Ceftazydym 2,0g x 1 fiol. – 4 000 op., Ceftriakson 1,0g x 1 fiol. – 6 500 op., Ceftriakson 2,0g x 1 fiol. – 2 000 op., Cefuroksym 250mg x 10 tabl. – 10 op., Cefuroksym 500mg x 10 tabl. – 80 op., Cefuroksym 750mg x 1 fiol. – 4 500 op., Cefuroksym 1,5g x 1 fiol. – 700 op., Ciprofloksacyna 200mg/100ml x 40 poj. – 30 op., Ciprofloksacyna 250mg x 10 tabl.powl. – 60 op., Ciprofloksacyna 400mg/200ml x 20 poj. – 140 op, Ciprofloksacyna 500mg x 10 tabl.powl. – 400 op., Gentamycyna 80mg/80ml x 10 fl. – 20 op., Gentamycyna 240mg/80ml x 10 fl. – 40 op., Ibuprofen 600mg/100ml x 20 fl. – 100 op., Lignocain 2%/20ml x 20 amp. – 400 op., Linezolid 600mg/300ml x 1 worek – 2 500 op., Metronidazol 500mg /100 ml x 40 fl. – 200 op., Paracetamol 1,0 g/100 ml x 10 fl. Plastik – 2 500 op., Tobramycyna 240 mg/80 ml x 10 fl. – 350 op., Tobramycyna 360 mg/120 ml x 10 fl. – 30 op.

      44. Award criteria:
          
      45. Estimated value:
          
          
      46. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 6
          This contract is subject to renewal: no
          
      47. Information about the limits on the number of candidates to be invited:
          
      48. Information about variants:
          Variants will be accepted: no
          
      49. Information about options:
          Options: no
      50. Information about electronic catalogues:
          
          
      51. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      52. Additional information:
          
      53. Title:
          

          Pakiet Nr 5

          Lot No: 5
          
      54. Additional CPV code(s):
          33651100, 33661200
          
      55. Place of performance:
          Main site or place of performance:

          Instytut Gruźlicy i Chorób Płuc z siedzibą w Warszawie 01-138, ul. Płocka 26 - Apteka.

      56. Description of the procurement:
          

          Pakiet Nr 5: Amikacyna 500mg/100ml x 10 fl. – 100 op., Amikacyna 1,0g/100ml x 10 fl. – 150 op., Cefepime 1,0 g x 10 fiol. – 5 op., Cefepime 2,0 g x 10 fiol. – 5 op., Ceftazydym 1,0 g x 10 fiol. – 300 op., Ceftazydym 2,0 g x 10 fiol. – 300 op., Ceftriakson 1,0 g x 10 fiol. – 600 op., Ceftriakson 2,0 g x 10 fiol. – 300 op., Ciprofloksacyna 200mg/100ml x 20 fl. – 100 op., Ciprofloksacyna 400mg/200ml x 20 fl. – 100 op., Flukonazol 200mg/100ml x 10 fl. – 300 op., Imipenrm/Cilastatin 500mg/500mg x 10 fiol. – 150 op., Kalium Chloratum 15% x 20ml x 20 amp. – 400 op., Klindamycyna 300mg/2 ml x 5 amp. – 200 op., Klindamycyna 600mg/4 ml x 5 amp. – 600 op., Levofloxacyna 250mg/50ml x 10 fl. – 200 op., Levofloxacyna 500mg/100ml x 10 fl. – 800 op., Linezolid 600mg/300ml x 10 fl. – 180 op., Lidokaina, 20 mg/ml x 5 amp. 20 ml – 600 op., Lidokaina, 20 mg/ml x 10 amp. 5 ml – 20 op., Meropenem 500mg x 10 fiol. – 150 op., Meropenem 1000mg x 10 fiol. – 2 200 op., Norepinefryna 4mg/4ml x 10 amp. – 400 op., Natrium Chloratum 0,9% x 10ml x 50 amp. – 2 100 op., Piperacillin/Tazobactam 4,0g/0,5g x 10 fiol. – 400 op., Propofol 200mg/20ml x 5szt. – 2 000 op., Propofol 500mg/50ml x 1 fiol. – 5 000 op., Sugammadex 200 mg /2 ml, op 10 amp. – 80 op., Rokuronium 100mg/10ml x 10 fiol. – 150 op., Fosfomycyna prosz.do sporz. roztw. do inf. 2g /100 ml x 10 fl. – 10 op., Fosfomycyna prosz.do sporz. roztw. do inf. 4g /100 ml x 10 fl. – 20 op.

      57. Award criteria:
          
      58. Estimated value:
          
          
      59. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 6
          This contract is subject to renewal: no
          
      60. Information about the limits on the number of candidates to be invited:
          
      61. Information about variants:
          Variants will be accepted: no
          
      62. Information about options:
          Options: no
      63. Information about electronic catalogues:
          
          
      64. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      65. Additional information:
          
      66. Title:
          

          Pakiet Nr 6

          Lot No: 6
          
      67. Additional CPV code(s):
          33651100
          
      68. Place of performance:
          Main site or place of performance:

          Instytut Gruźlicy i Chorób Płuc z siedzibą w Warszawie 01-138, ul. Płocka 26 - Apteka.

      69. Description of the procurement:
          

          Pakiet Nr 6: Ceftazidime/ Avibactam (2 g+0,5 g) x 10 fiol. – 10 op., Ceftaroline fosamil 600 mg x 10 fiol. – 20 op., Tigecycline proszek do sporz. roztw. do inf. 50 mg x 10 fiol. – 20 op.

      70. Award criteria:
          
      71. Estimated value:
          
          
      72. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 6
          This contract is subject to renewal: no
          
      73. Information about the limits on the number of candidates to be invited:
          
      74. Information about variants:
          Variants will be accepted: no
          
      75. Information about options:
          Options: no
      76. Information about electronic catalogues:
          
          
      77. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      78. Additional information:
          
      79. Title:
          

          Pakiet Nr 7

          Lot No: 7
          
      80. Additional CPV code(s):
          33651100, 33615100
          
      81. Place of performance:
          Main site or place of performance:

          Instytut Gruźlicy i Chorób Płuc z siedzibą w Warszawie 01-138, ul. Płocka 26 - Apteka.

      82. Description of the procurement:
          

          Pakiet Nr 7: Amoksycylina 1,0 g x 20 tabl./ tabl. powl. – 10 op., Amoksycylina+ Kw.Klawulanowy 625 mg (500mg+125mg) x 21tabl. – 20 op., Amoksycylina+ Kw.Klawulanowy 1000 mg (875mg+125mg) x 21tabl. – 300 op., Amoksycylina+Kw.Klawulanowy 1,2 g (1,0 g+0,2 g) x 1 fiol. – 2 000 op., Amoksycylina+Kw.Klawulanowy 2,2 g (2,0 g+0,2 g) x 1 fiol. – 200 op., Ampicylina 1,0 g x 1 fiol. – 400 op., Ampicylina+ Sulbactam(1,0g+0,5g) x 1 fiol. – 100 op. , Ampicylina+ Sulbactam(2,0g+1,0g) x 1 fiol. – 10 op., Azytromycyna 250 mg x 6 tabl. – 50 op., Azytromycyna 500 mg x 6 tabl. – 100 op., Benzylpenicillin 1 mln j.m. x 1 fiol. – 10 op., Benzylpenicillin 3 mln j.m. x 1 fiol. – 70 op., Benzylpenicillin 5 mln j.m. x 1 fiol. – 10 op., Ceftriakson 1000 mg x 1 fiol. – 4 000 op., Cefuroksym 250 mg x 10 tabl. powl. – 10 op., Cefuroksym 500 mg x 10 tabl. powl. – 50 op., Cefuroksym 750 mg x 1 fiol. – 2 000 op., Cefuroksym 1500 mg x1 fiol. – 500 op., Cloxacillin 1,0 g x 1 fiol. – 400 op., Cloxacillin 500 mg x 16 tabl. powl. – 15 op.; Colistyna 1 mln j.m. x 20 fiol. – 850 op., Dobutamina 250 mg x 1 fiol. – 500 op., Doxycyklina 100 mg x 10 kaps. – 30 op., Doxycyklina 100 mg/ 5ml x 10 amp. – 5 op., Insulina ludzka krótkodziałająca 300j.m./ 3 ml x 5 wkładów – 2 op., Insulina ludzka długodziałająca 300j.m./ 3 ml x 5 wkładów – 2 op., Insulina ludzka o pośrednim czasie działnia (MIX-3) 300j.m./ 3 ml x 5 wkładów – 2 op., Izoniazyd+Rifampicyna(150mg+100mg)x100 kaps. – 4 op., izoniazyd+Rifampicyna(300mg+150mg)x100 kaps. – 8 op., Klarytromycyna 500 mg x 1 fiol. – 150 op., Klarytromycyna 500 mg x 14 tabl. powl. – 160 op., Neomycyna 250 mg x 16 tabl. – 12 op., Rifampicyna 300 mg x 100 kaps. – 8 op., Rifampicyna 150 mg x 100 kaps. – 3 op.

      83. Award criteria:
          
      84. Estimated value:
          
          
      85. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 6
          This contract is subject to renewal: no
          
      86. Information about the limits on the number of candidates to be invited:
          
      87. Information about variants:
          Variants will be accepted: no
          
      88. Information about options:
          Options: no
      89. Information about electronic catalogues:
          
          
      90. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      91. Additional information:
          
      92. Title:
          

          Pakiet Nr 8

          Lot No: 8
          
      93. Additional CPV code(s):
          33651200
          
      94. Place of performance:
          Main site or place of performance:

          Instytut Gruźlicy i Chorób Płuc z siedzibą w Warszawie 01-138, ul. Płocka 26 - Apteka.

      95. Description of the procurement:
          

          Pakiet Nr 8: Voriconazole 200 mg x 1 fiol. – 700 op.

      96. Award criteria:
          
      97. Estimated value:
          
          
      98. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 6
          This contract is subject to renewal: no
          
      99. Information about the limits on the number of candidates to be invited:
          
      100. Information about variants:
           Variants will be accepted: no
           
      101. Information about options:
           Options: no
      102. Information about electronic catalogues:
           
           
      103. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      104. Additional information:
           
      105. Title:
           

           Pakiet Nr 9

           Lot No: 9
           
      106. Additional CPV code(s):
           33651100
           
      107. Place of performance:
           Main site or place of performance:

           Instytut Gruźlicy i Chorób Płuc z siedzibą w Warszawie 01-138, ul. Płocka 26 - Apteka.

      108. Description of the procurement:
           

           Pakiet Nr 9: Meropenem 500 mg x 10 fiol. – 150 op., Meropenem 1000 mg x 10 fiol. – 2 200 op.

      109. Award criteria:
           
      110. Estimated value:
           
           
      111. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 6
           This contract is subject to renewal: no
           
      112. Information about the limits on the number of candidates to be invited:
           
      113. Information about variants:
           Variants will be accepted: no
           
      114. Information about options:
           Options: no
      115. Information about electronic catalogues:
           
           
      116. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      117. Additional information:
           
      118. Title:
           

           Pakiet Nr 10

           Lot No: 10
           
      119. Additional CPV code(s):
           33651100
           
      120. Place of performance:
           Main site or place of performance:

           Instytut Gruźlicy i Chorób Płuc z siedzibą w Warszawie 01-138, ul. Płocka 26 - Apteka.

      121. Description of the procurement:
           

           Pakiet Nr 10: Vancomycin proszek do sporz. roztw. do inf. 500 mg x 1 fiol.- 1 800 op., Vancomycin proszek do sporz. roztw. do inf. 1000 mg x 1 fiol. – 2 000 op.

      122. Award criteria:
           
      123. Estimated value:
           
           
      124. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 6
           This contract is subject to renewal: no
           
      125. Information about the limits on the number of candidates to be invited:
           
      126. Information about variants:
           Variants will be accepted: no
           
      127. Information about options:
           Options: no
      128. Information about electronic catalogues:
           
           
      129. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      130. Additional information:
           
      131. Title:
           

           Pakiet Nr 11

           Lot No: 11
           
      132. Additional CPV code(s):
           33651200
           
      133. Place of performance:
           Main site or place of performance:

           Instytut Gruźlicy i Chorób Płuc z siedzibą w Warszawie 01-138, ul. Płocka 26 - Apteka.

      134. Description of the procurement:
           

           Pakiet Nr 11: Amphotericin B 50 mg proszek do sporządzenia wlewów i.v. x 1 fiol. – 50 op.

      135. Award criteria:
           
      136. Estimated value:
           
           
      137. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 6
           This contract is subject to renewal: no
           
      138. Information about the limits on the number of candidates to be invited:
           
      139. Information about variants:
           Variants will be accepted: no
           
      140. Information about options:
           Options: no
      141. Information about electronic catalogues:
           
           
      142. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      143. Additional information:
           
      144. Title:
           

           Pakiet Nr 12

           Lot No: 12
           
      145. Additional CPV code(s):
           33651100
           
      146. Place of performance:
           Main site or place of performance:

           Instytut Gruźlicy i Chorób Płuc z siedzibą w Warszawie 01-138, ul. Płocka 26 - Apteka.

      147. Description of the procurement:
           

           Pakiet Nr 12: Amphotericin B zawiesina liposomalna do wlewów i.v. 5mg/1ml x 10 fiol.a 20 ml – 20 op.

      148. Award criteria:
           
      149. Estimated value:
           
           
      150. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 6
           This contract is subject to renewal: no
           
      151. Information about the limits on the number of candidates to be invited:
           
      152. Information about variants:
           Variants will be accepted: no
           
      153. Information about options:
           Options: no
      154. Information about electronic catalogues:
           
           
      155. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      156. Additional information:
           
3. Section III
   1. Conditions for participation:
      1. Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers:
         List and brief description of conditions:

         O zamówienie mogą ubiegać się wykonawcy, którzy są uprawnieni do hurtowego obrotu produktami leczniczymi objętymi przedmiotem zamówienia, zgodnie z ustawą z dnia 6 września 2001 r. - Prawo farmaceutyczne (Dz. U. z 2022 r. poz. 2301 z późn. zm.).

      2. Economic and financial standing:
         
      3. Technical and professional ability:
         
      4. Information about reserved contracts:
         
   2. Conditions related to the contract:
      1. Information about a particular profession:
         Contract performance conditions:

         1. Wykonawca jest zobowiązany do zrealizowania przedmiotu zamówienia w okresie 6 miesięcy od daty zawarcia umowy.

         2. Projektowane postanowienia umowy oraz okoliczności zmiany umowy zostały określone w Załącznik Nr 4 do Specyfikacji Warunków Zamówienia.

      2. Information about staff responsible for the performance of the contract:
         
4. Section IV
5. Description:
   1. Type of procedure:
      Open procedureJustification:

      Zgodnie z art 138 ust. 4 ustawy z dnia 11 września 2019 r. Prawo zamówień publicznych (Dz.U. z 2023 r. poz. 1605), Zamawiający może wyznaczyć termin składania ofert o 5 dni krótszy niż określony w art. 138 ust. 1 ustawy Pzp, jeżeli składanie ofert odbywa się w całości przy użyciu środków komunikacji elektronicznej, w sposób określony w art. 63 ust. 1 ustawy Pzp.

   2. Information about a framework agreement or a dynamic purchasing system:
      
   3. Information about reduction of the number of solutions or tenders during negotiation or dialogue:
      
   4. Information about negotiation:
      
   5. Information about electronic auction:
      
   6. Information about the Government Procurement Agreement (GPA):
      The procurement is covered by the Government Procurement Agreement: yes
6. Administrative information:
   1. Previous publication concerning this procedure:
      
   2. Time limit for receipt of tenders or requests to participate:
      Date: 2023-10-26
      Local time: 09:00
      
   3. Estimated date of dispatch of invitations to tender or to participate to selected candidates:
      
   4. Languages in which tenders or requests to participate may be submitted:
      PL
   5. Minimum time frame during which the tenderer must maintain the tender:
      Tender must be valid until: 2024-01-23
      (from the date stated for receipt of tender)
      
   6. Conditions for opening of tenders:
      Date: 2023-10-26
      Local time: 09:15
      Place:

      Otwarcie ofert nastąpi poprzez upublicznienie wczytanych na Platformie Ofert w dniu 23.10.2023 r. o godz. 09:15 w siedzibie zamawiającego budynek „E”, Dział Zamówień Publicznych i Zaopatrzenia.

Источник закупки

Импорт - Экспорт по стране Польша